RxDoctor Payments Data

Chian Kwoh, MD

Rheumatology · Tucson, AZNPI 1730153131

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $10,437 of the $11,593 with a category attached, or 90.0%. EMD Serono, Inc. accounts for 84.6% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $8,589 and has fallen 99.3% since, to $56 in 2025.

$11,593in general payments, 2019–2025

Across 12 payments — averaging $966.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • EMD Serono, Inc.$10K
  • GSK$2K
  • Astrazeneca UK Limited$56
$179,997in research payments, 2019–2025

Across 42 payments — averaging $4285.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • E.r. Squibb & Sons, L.L.C.$71K
  • GSK$31K
  • Novartis$30K
  • EMD Serono, Inc.$23K
  • AbbVie$14K
  • Eli Lilly$7K
  • plus $4K from 2 others

What the payments were for

  • Consulting fees$10,43790%
  • Travel & lodging$1,0999%
  • Food & beverage$560%

General payments by program year

19
20
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
EMD Serono, Inc.9$9,809
GSK2$1,728
Astrazeneca UK Limited1$56

How this compares

$11,593 in reported general payments places this provider in the 65th percentile of 102 rheumatology providers in Arizona.

See all rheumatology providers in Arizona

Medicare billing

Part B allowed, 2024
$9,056
Medicare patients
72
Services billed
90

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other rheumatology in Tucson

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →